Showing 401-410 of 18069 results for "".
Underrecognition of Diabetes in Cardiology Practice
https://reachmd.com/programs/lipid-luminations/underrecognition-of-diabetes-in-cardiology-practice/6779/Joining Dr. Alan Brown is Revathi Balakrishnan, MD, MPH, a general cardiology fellow at NYU and winner of the NLA Young Investigator Competition. Dr. Balakrishnan's research, titled "Prevalence of unrecognized prediabetes, diabetes and metabolic syndrome in patients undergoing non-urgent PCI," foundThe Relationship Between Diabetes and Periodontal Disease
https://reachmd.com/programs/diabetes-discourse/the-relationship-between-diabetes-and-periodontal-disease/5678/Periodontitis is considered the sixth major diabetes-related complication. What do healthcare professionals need to know to help their patients with diabetes? Join guest host and registered dietitian Janice Baker and her guest, dentist in San Diego, California, Dr. Timothy Garofolo, as they discussEmerging Patterns in Diabetes Management
https://reachmd.com/programs/focus-on-pharmacy/emerging-patterns-in-diabetes-management/3532/It is estimated that a diabetes-related death occurs around the world once every ten seconds. In that same ten-second interval, two citizens of the world develop the disease. As general global trends persist toward a decrease in activity and an increase in food consumption, what will we see as partNew Drug for Diabetic Patients in Phase 2 Trials
https://reachmd.com/programs/clinicians-roundtable/new-drug-for-diabetic-patients-in-phase-2-trials/125/Dr. Berkowitz, President and CEO of Alteon, Inc. discusses a new drug that they are developing for diabetic patients.New Drug for Cardiovascular Complications-Diabetes
https://reachmd.com/programs/clinicians-roundtable/new-drug-for-cardiovascular-complications-diabetes/124/Dr. Noah Berkowitz talks about a new test available commercially that determines risk level of cardiovascular complications for diabetic patients. He also discusses a new drug that his company Alteon, Inc. is developing to treat these complications.Diabetes: Why monitoring the FBS is not enough
https://reachmd.com/programs/clinicians-roundtable/diabetes-why-monitoring-the-fbs-is-not-enough/1740/Dr. Antonio Ceriello, Professor of Diabetes and Endocrinology at Warwick University in the UK, is interviewed by Dr. Shira Johnson. Learn why monitoring your patients FBS is not enough to predict risks of continued hyperglycemia.Addressing Diabetes Across Political Divides
https://reachmd.com/programs/clinicians-roundtable/addressing-diabetes-across-political-divides/1684/Dr. Maurice Pickard speaks with Dr. Norbert Goldfield, Executive Director of Healing Across the Divides, about how changes in physical activity, diet and increasing poverty are shared by Israelies and Palestinians and contribute to mutually rising incidences of diabetes.Evaluating the Importance of Oral Health in T1D
https://reachmd.com/programs/diabetes-discourse/evaluating-importance-of-oral-health-in-t1d/13633/Find out more about the connection between oral health and type 1 diabetes.Bridging the Gap: Lipid Management in ASCVD Patients with Diabetes to Reduce CV Risk
https://reachmd.com/programs/medical-industry-feature/bridging-the-gap-lipid-management-in-ascvd-patients-with-diabetes-to-reduce-cv-risk/26670/Learn about a treatment option and the potential impacts of lipid management on cardiovascular risk in ASCVD patients with diabetes.How the Artificial Pancreas Can Help Diabetic Patients
https://reachmd.com/programs/diabetes-discourse/how-the-artificial-pancreas-can-help-diabetic-patients/16365/Find out how the artificial pancreas can help improve the quality of life in diabetic patients with this brief review.